Floatz logo

9 assets in Autoimmune Encephalitis

Therapeutic assets addressing Autoimmune Encephalitis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Autoimmune Encephalitis
Tongji HospitalP2BB (64)
Human Immunoglobulins
Autoimmune Encephalitis
University of UtahP2CCC (53)
Immunoglobulin G2, Anti-(Human Cd19 (Antigen)) (Synthetic Human Monoclonal Medi-551 Heavy Chain), Disulfide With Synthetic Human Monoclonal Medi-551 .Kappa.-Chain, Dimer
Autoimmune Encephalitis
University of UtahP2CCC (53)
Rituximab
Autoimmune Encephalitis
University of CambridgeP2CCC (53)
Fludarabine
Autoimmune Encephalitis
Tongji HospitalP1CCC (50)
Universal Cd19 Car-Γδt Cell
Autoimmune Encephalitis
Tongji HospitalP1CC (43)
Bcma Targeted Car T-Cells
Autoimmune Encephalitis
Tongji HospitalEarly P1C (39)
ct103a cells
Autoimmune Encephalitis
Tongji HospitalEarly P1C (39)
Ucar T-Cell
Autoimmune Encephalitis
Tianjin Huanhu HospitalEarly P1C (39)